| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Published online before print May 18, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |

@,
¶,
,
,
,
,
,
,
,
,
,
,
||||,
,
,
,
,
***,
***,
,


From the Departments of Neurology,* Pathology and Immunology,
and Psychiatry,|||| Alzheimer's Disease Research Center,
Washington University School of Medicine, St. Louis, Missouri; the Center for Neurodegenerative Disease Research,
Department of Pathology and Laboratory Medicine, Institute on Aging,*** University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; the Center for Neuropathology and Prion Research,¶ Ludwig-Maximilians University, Munich, Germany; the Department of Pathology,|| Cognitive Neurology and Alzheimer Disease Center,** Northwestern University Medical School, Chicago, Illinois; the Department of Pathology,
Aalborg Hospital, Aalborg, Denmark; the Department of Neuropathology,
Academic Medical Centre, Amsterdam, The Netherlands; the Neuropathology Laboratory,
Department of Pathology, University of Texas Southwestern Medical School, Dallas, Texas; the Rush Alzheimer's Disease Center,¶¶ Rush University Medical School, Chicago, Illinois; and the Department of Pathology and Laboratory Medicine,

Vancouver General Hospital, Vancouver, British Columbia, Canada
@ To whom correspondence should be addressed. E-mail: cairns{at}wustl.edu.
| Abstract |
|---|
TAR DNA-binding protein 43 (TDP-43) is a major pathological protein of sporadic and familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions (FTLD-U) with or without motor neuron disease (MND). Thus, TDP-43 defines a novel class of neurodegenerative diseases called TDP-43 proteinopathies. We performed ubiquitin and TDP-43 immunohistochemistry on 193 cases of familial and sporadic FTLD with or without MND. On selected cases, immunoelectron microscopy and biochemistry were performed. Clinically defined frontotemporal dementias (FTDs) included four groups: 1) familial FTD with mutations in progranulin (n = 36), valosin-containing protein (n = 5), charged multivesicular body protein 2B (n = 4), and linked to chromosome 9p (n = 7); 2) familial cases of FTD with unknown gene association (n = 29); 3) sporadic FTD (n = 72); and 4) familial and sporadic FTD with MND (n = 40). Our studies confirm that the spectrum of TDP-43 proteinopathies includes most cases of sporadic and familial FTLD-U with and without MND and expand this disease spectrum to include reported families with FTD linked to chromosome 9p but not FTD with charged multivesicular body protein 2B mutations. Thus, despite significant clinical, genetic, and neuropathological heterogeneity of FTLD-U, TDP-43 is a common pathological substrate underlying a large subset of these disorders, thereby implicating TDP-43 in novel and unifying mechanisms of FTLD pathogenesis.
This article has been cited by other articles:
![]() |
R. Rademakers, J. L. Eriksen, M. Baker, T. Robinson, Z. Ahmed, S. J. Lincoln, N. Finch, N. J. Rutherford, R. J. Crook, K. A. Josephs, et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia Hum. Mol. Genet., December 1, 2008; 17(23): 3631 - 3642. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Seelaar, W. Kamphorst, S. M. Rosso, A. Azmani, R. Masdjedi, I. de Koning, J. A. Maat-Kievit, B. Anar, L. D. Kaat, G. J. Breedveld, et al. Distinct genetic forms of frontotemporal dementia Neurology, October 14, 2008; 71(16): 1220 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Igaz, L. K. Kwong, Y. Xu, A. C. Truax, K. Uryu, M. Neumann, C. M. Clark, L. B. Elman, B. L. Miller, M. Grossman, et al. Enrichment of C-Terminal Fragments in TAR DNA-Binding Protein-43 Cytoplasmic Inclusions in Brain but not in Spinal Cord of Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Am. J. Pathol., July 1, 2008; 173(1): 182 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Chen-Plotkin, F. Geser, J. B. Plotkin, C. M. Clark, L. K. Kwong, W. Yuan, M. Grossman, V. M. Van Deerlin, J. Q. Trojanowski, and V. M.-Y. Lee Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration Hum. Mol. Genet., May 15, 2008; 17(10): 1349 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Winton, L. M. Igaz, M. M. Wong, L. K. Kwong, J. Q. Trojanowski, and V. M.-Y. Lee Disturbance of Nuclear and Cytoplasmic TAR DNA-binding Protein (TDP-43) Induces Disease-like Redistribution, Sequestration, and Aggregate Formation J. Biol. Chem., May 9, 2008; 283(19): 13302 - 13309. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Josephs, J. L. Whitwell, D. S. Knopman, W. T. Hu, D. A. Stroh, M. Baker, R. Rademakers, B. F. Boeve, J. E. Parisi, G. E. Smith, et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype Neurology, May 6, 2008; 70(19_Part_2): 1850 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. A. Mackenzie, D. Foti, J. Woulfe, and T. A. Hurwitz Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions Brain, May 1, 2008; 131(5): 1282 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shankaran, A. Capell, A. T. Hruscha, K. Fellerer, M. Neumann, B. Schmid, and C. Haass Missense Mutations in the Progranulin Gene Linked to Frontotemporal Lobar Degeneration with Ubiquitin-immunoreactive Inclusions Reduce Progranulin Production and Secretion J. Biol. Chem., January 18, 2008; 283(3): 1744 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Neumann, L. K. Kwong, D. M. Sampathu, J. Q. Trojanowski, and V. M.-Y. Lee TDP-43 Proteinopathy in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis: Protein Misfolding Diseases Without Amyloidosis Arch Neurol, October 1, 2007; 64(10): 1388 - 1394. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |